These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 10380351

  • 1. Development of plasma kallikrein selective inhibitors.
    Okada Y, Tsuda Y, Tada M, Wanaka K, Hijikata-Okunomiya A, Okamoto U, Okamoto S.
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [Abstract] [Full Text] [Related]

  • 2. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
    Fukumizu A, Tsuda Y, Wanaka K, Tada M, Okamoto S, Hijikata-Okunomiya A, Okada Y.
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1141-4. PubMed ID: 10478469
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ.
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis.
    Gohda K, Teno N, Wanaka K, Tsuda Y.
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):571-7. PubMed ID: 21992704
    [Abstract] [Full Text] [Related]

  • 9. Development of selective inhibitors against plasma kallikrein.
    Teno N, Wanaka K, Okada Y, Tsuda Y, Okamoto U, Hijikata-Okunomiya A, Naito T, Okamoto S.
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2930-6. PubMed ID: 1839246
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Uchiba M, Okajima K, Murakami K, Okabe H, Okamoto S, Okada Y.
    Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
    [Abstract] [Full Text] [Related]

  • 12. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
    Markowska A, Bruzgo M, Surażyński A, Midura-Nowaczek K.
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
    [Abstract] [Full Text] [Related]

  • 13. Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin.
    Markland W, Ley AC, Ladner RC.
    Biochemistry; 1996 Jun 18; 35(24):8058-67. PubMed ID: 8672510
    [Abstract] [Full Text] [Related]

  • 14. [Method of simultaneous determination of kallikrein, plasmin and thrombin precursors and inhibitors in human blood plasma].
    Gomazkov OA, Komissarova NV.
    Biull Eksp Biol Med; 1976 May 18; 81(5):632-4. PubMed ID: 132976
    [Abstract] [Full Text] [Related]

  • 15. Purification method for human plasma kallikrein by a new affinity chromatography.
    Tada M, Wanaka K, Okamoto S, Okamoto U, Nakaya Y, Horie N, Hijikata-Okunomiya A, Tsuda Y, Okada Y.
    Biol Pharm Bull; 1998 Feb 18; 21(2):105-8. PubMed ID: 9514601
    [Abstract] [Full Text] [Related]

  • 16. Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.
    Hashimoto M, Oiwa K, Matsuo O, Ueshima S, Okada K, Okada Y, Okamoto S, Giddings JC, Yamamoto J.
    Thromb Haemost; 2003 May 18; 89(5):820-5. PubMed ID: 12719778
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 4-Heterocyclohexanone-based inhibitors of the serine protease plasmin.
    Sanders TC, Seto CT.
    J Med Chem; 1999 Jul 29; 42(15):2969-76. PubMed ID: 10425106
    [Abstract] [Full Text] [Related]

  • 20. A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
    Okamoto S, Wanaka K, Hijikata-Okunomiya A, Okada Y, Katsuura Y.
    Agents Actions Suppl; 1992 Jul 29; 38 ( Pt 1)():198-205. PubMed ID: 1466271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.